...
search icon
trvn-img

Trevena Inc, Common Stock

TRVN

NASDAQ

$1.11

+$0.03

(2.78%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$958.80K
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
192.00
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.62
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$0.95 L
$7.85 H
$1.11

About Trevena Inc, Common Stock

Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV734, a small molecule G protein biased ligand of the MOR, which has completed phase I studies for the treatment of moderate-to-severe acute and chronic pain; and TRV045, a novel S1P modulator for managing chronic pain. Trevena, Inc. was incorporated in 2007 and is headquartered in Chesterbrook, Pennsylvania. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameTRVNSectorS&P500
1-Week Return-0.46%1.22%3%
1-Month Return-2.7%1.56%3.83%
3-Month Return-16.08%-7.42%8.24%
6-Month Return-36.09%-3.4%3.12%
1-Year Return-79.91%-7.99%11.97%
3-Year Return-99.6%3.5%57.3%
5-Year Return-99.89%36.42%101.7%
10-Year Return-99.97%81.06%199.52%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue31.00K3.07M567.00K(418.00K)3.13M[{"date":"2019-12-31","value":0.99,"profit":true},{"date":"2020-12-31","value":98.21,"profit":true},{"date":"2021-12-31","value":18.14,"profit":true},{"date":"2022-12-31","value":-13.38,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Cost of Revenue108.00K182.00K954.00K3.02M1.67M[{"date":"2019-12-31","value":3.58,"profit":true},{"date":"2020-12-31","value":6.03,"profit":true},{"date":"2021-12-31","value":31.61,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":55.33,"profit":true}]
Gross Profit(77.00K)2.89M(387.00K)(3.44M)1.46M[{"date":"2019-12-31","value":-2.67,"profit":false},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-13.4,"profit":false},{"date":"2022-12-31","value":-119.02,"profit":false},{"date":"2023-12-31","value":50.4,"profit":true}]
Gross Margin(248.39%)94.07%(68.25%)822.01%46.56%[{"date":"2019-12-31","value":-30.22,"profit":false},{"date":"2020-12-31","value":11.44,"profit":true},{"date":"2021-12-31","value":-8.3,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":5.66,"profit":true}]
Operating Expenses26.50M32.37M51.54M52.94M38.41M[{"date":"2019-12-31","value":50.06,"profit":true},{"date":"2020-12-31","value":61.15,"profit":true},{"date":"2021-12-31","value":97.35,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":72.56,"profit":true}]
Operating Income(26.58M)(29.48M)(51.92M)(56.38M)(35.29M)[{"date":"2019-12-31","value":-2658000000,"profit":false},{"date":"2020-12-31","value":-2948500000,"profit":false},{"date":"2021-12-31","value":-5192500000,"profit":false},{"date":"2022-12-31","value":-5637500000,"profit":false},{"date":"2023-12-31","value":-3528800000,"profit":false}]
Total Non-Operating Income/Expense1.20M627.00K498.00K1.90M(5.80M)[{"date":"2019-12-31","value":62.95,"profit":true},{"date":"2020-12-31","value":33,"profit":true},{"date":"2021-12-31","value":26.21,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-305.11,"profit":false}]
Pre-Tax Income(24.87M)(29.07M)(51.59M)(53.67M)(39.97M)[{"date":"2019-12-31","value":-2487100000,"profit":false},{"date":"2020-12-31","value":-2906900000,"profit":false},{"date":"2021-12-31","value":-5158800000,"profit":false},{"date":"2022-12-31","value":-5367000000,"profit":false},{"date":"2023-12-31","value":-3997100000,"profit":false}]
Income Taxes3.19M300.00K(428.00K)(2.71K)318.00K[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":9.42,"profit":true},{"date":"2021-12-31","value":-13.44,"profit":false},{"date":"2022-12-31","value":-0.08,"profit":false},{"date":"2023-12-31","value":9.98,"profit":true}]
Income After Taxes(28.06M)(29.37M)(51.16M)(53.67M)(40.29M)[{"date":"2019-12-31","value":-2805600000,"profit":false},{"date":"2020-12-31","value":-2936900000,"profit":false},{"date":"2021-12-31","value":-5116000000,"profit":false},{"date":"2022-12-31","value":-5366729500,"profit":false},{"date":"2023-12-31","value":-4028900000,"profit":false}]
Income From Continuous Operations(24.87M)(29.07M)(51.59M)(53.67M)(30.77M)[{"date":"2019-12-31","value":-2487100000,"profit":false},{"date":"2020-12-31","value":-2906900000,"profit":false},{"date":"2021-12-31","value":-5158800000,"profit":false},{"date":"2022-12-31","value":-5367000000,"profit":false},{"date":"2023-12-31","value":-3076600000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(28.06M)(29.37M)(51.16M)(53.67M)(40.29M)[{"date":"2019-12-31","value":-2805600000,"profit":false},{"date":"2020-12-31","value":-2936900000,"profit":false},{"date":"2021-12-31","value":-5116000000,"profit":false},{"date":"2022-12-31","value":-5366729500,"profit":false},{"date":"2023-12-31","value":-4028900000,"profit":false}]
EPS (Diluted)(6.75)(6.00)(7.75)(7.73)(3.13)[{"date":"2019-12-31","value":-675,"profit":false},{"date":"2020-12-31","value":-600,"profit":false},{"date":"2021-12-31","value":-775,"profit":false},{"date":"2022-12-31","value":-773,"profit":false},{"date":"2023-12-31","value":-313,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

TRVN
Cash Ratio 2.21
Current Ratio 2.42

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

TRVN
ROA (LTM) -62.39%
ROE (LTM) -1014.58%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

TRVN
Debt Ratio Lower is generally better. Negative is bad. 2.21
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. -1.21

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

TRVN
Trailing PE NM
Forward PE NM
P/S (TTM) 1.76
P/B 0.36
Price/FCF NM
EV/R 45.90
EV/Ebitda 0.21
PEG NM

FAQs

What is Trevena Inc share price today?

Trevena Inc (TRVN) share price today is $1.11

Can Indians buy Trevena Inc shares?

Yes, Indians can buy shares of Trevena Inc (TRVN) on Vested. To buy Trevena Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in TRVN stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Trevena Inc be purchased?

Yes, you can purchase fractional shares of Trevena Inc (TRVN) via the Vested app. You can start investing in Trevena Inc (TRVN) with a minimum investment of $1.

How to invest in Trevena Inc shares from India?

You can invest in shares of Trevena Inc (TRVN) via Vested in three simple steps:

  • Click on Sign Up or Invest in TRVN stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Trevena Inc shares
What is Trevena Inc 52-week high and low stock price?

The 52-week high price of Trevena Inc (TRVN) is $7.85. The 52-week low price of Trevena Inc (TRVN) is $0.95.

What is Trevena Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Trevena Inc (TRVN) is 0.36

What is the Market Cap of Trevena Inc?

The market capitalization of Trevena Inc (TRVN) is $958.80K

What is Trevena Inc’s stock symbol?

The stock symbol (or ticker) of Trevena Inc is TRVN

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top